RISS 학술연구정보서비스

검색
다국어 입력

http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

변환된 중국어를 복사하여 사용하시면 됩니다.

예시)
  • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
  • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
닫기
    인기검색어 순위 펼치기

    RISS 인기검색어

      KCI등재 SCIE SCOPUS

      Characteristics and Cardiomyogenic Potential of Rat Fetal Cardiac Progenitor Cells at Different Developmental Stage

      한글로보기

      https://www.riss.kr/link?id=A105870961

      • 0

        상세조회
      • 0

        다운로드
      서지정보 열기
      • 내보내기
      • 내책장담기
      • 공유하기
      • 오류접수

      부가정보

      다국어 초록 (Multilingual Abstract)

      In recent years, several kinds of cardiac progenitor cells have been identified and isolated from heart tissue.
      These cells showed differentiation potential into cardiomyocytes, smooth muscle cells, and endothelial cells in vitro and in vivo. Morphogenetic events are tightly regulated during development to determine cell destiny and reshape the embryonic lineage. In this study, we directly compared the characteristics of rat fetal cardiac progenitor cells (rFCPCs) isolated from the chamber formation stage at embryonic day 12 (E12) and at the septation stage of E15. Both kinds of rFCPCs expressed mesenchymal stem cell markers (CD105, CD73, and CD29) but not CD34 and CD45. The E12 rFCPCs expressed a high level of Oct4 compared to E15 until passage 5 and showed a steep decline of Nkx2.5 expression at passage 5. However, Nkx2.5 expression at E15 was maintained until passage 5 and Oct4 expression slightly increased at passage 5. We also detected an intense staining for Oct4 antibody in E12 heart tissue sections. The average doubling time of the E12 rFCPCs from passage 3 to passage 15 was about 5 hours longer than E15. These cells could also be induced into cardiomyocytes expressing a-MHC, cTnT, cTnC, and Cx43 under cardiomyogenic culture conditions and rFCPCs at E15 showed more intense staining of a-MHC than cells at E12 by immunocytochemistry. Taken together, our results show that developmental differences between E12 and E15 may influence their properties and differentiation. Furthermore those differences should be considered when deciding on the optimal cell source for cell replacement therapy in cardiovascular regeneration.
      번역하기

      In recent years, several kinds of cardiac progenitor cells have been identified and isolated from heart tissue. These cells showed differentiation potential into cardiomyocytes, smooth muscle cells, and endothelial cells in vitro and in vivo. Morphog...

      In recent years, several kinds of cardiac progenitor cells have been identified and isolated from heart tissue.
      These cells showed differentiation potential into cardiomyocytes, smooth muscle cells, and endothelial cells in vitro and in vivo. Morphogenetic events are tightly regulated during development to determine cell destiny and reshape the embryonic lineage. In this study, we directly compared the characteristics of rat fetal cardiac progenitor cells (rFCPCs) isolated from the chamber formation stage at embryonic day 12 (E12) and at the septation stage of E15. Both kinds of rFCPCs expressed mesenchymal stem cell markers (CD105, CD73, and CD29) but not CD34 and CD45. The E12 rFCPCs expressed a high level of Oct4 compared to E15 until passage 5 and showed a steep decline of Nkx2.5 expression at passage 5. However, Nkx2.5 expression at E15 was maintained until passage 5 and Oct4 expression slightly increased at passage 5. We also detected an intense staining for Oct4 antibody in E12 heart tissue sections. The average doubling time of the E12 rFCPCs from passage 3 to passage 15 was about 5 hours longer than E15. These cells could also be induced into cardiomyocytes expressing a-MHC, cTnT, cTnC, and Cx43 under cardiomyogenic culture conditions and rFCPCs at E15 showed more intense staining of a-MHC than cells at E12 by immunocytochemistry. Taken together, our results show that developmental differences between E12 and E15 may influence their properties and differentiation. Furthermore those differences should be considered when deciding on the optimal cell source for cell replacement therapy in cardiovascular regeneration.

      더보기

      참고문헌 (Reference)

      1 Milgrom-Hoffman M, "The heart endocardium is derived from vascular endothelial progenitors" 138 : 4777-4787, 2011

      2 Bruneau BG, "The developmental genetics of congenital heart disease" 451 : 943-948, 2008

      3 Tanaka M, "The cardiac homeobox gene Csx/Nkx2.5 lies genetically upstream of multiple genes essential for heart development" 126 : 1269-1280, 1999

      4 Loh YH, "The Oct4 and Nanog transcription network regulates pluripotency in mouse embryonic stem cells" 38 : 431-440, 2006

      5 Goumans MJ, "TGF-beta1 induces efficient differentiation of human cardiomyocyte progenitor cells into functional cardiomyocytes in vitro" 1 : 138-149, 2007

      6 Chien KR, "Stem cells : lost in translation" 428 : 607-608, 2004

      7 Matar AA, "Stem cell therapy for cardiac dysfunction" 3 : 440-, 2014

      8 Cristofalo VJ, "Relationship between donor age and the replicative lifespan of human cells in culture : a reevaluation reevaluation" 95 : 10614-10619, 1998

      9 Laugwitz KL, "Postnatal isl1 ? cardioblasts enter fully differentiated cardiomyocyte lineages" 433 : 647-653, 2005

      10 Teo AK, "Pluripotency factors regulate definitive endoderm specifi-cation through eomesodermin" 25 : 238-250, 2011

      1 Milgrom-Hoffman M, "The heart endocardium is derived from vascular endothelial progenitors" 138 : 4777-4787, 2011

      2 Bruneau BG, "The developmental genetics of congenital heart disease" 451 : 943-948, 2008

      3 Tanaka M, "The cardiac homeobox gene Csx/Nkx2.5 lies genetically upstream of multiple genes essential for heart development" 126 : 1269-1280, 1999

      4 Loh YH, "The Oct4 and Nanog transcription network regulates pluripotency in mouse embryonic stem cells" 38 : 431-440, 2006

      5 Goumans MJ, "TGF-beta1 induces efficient differentiation of human cardiomyocyte progenitor cells into functional cardiomyocytes in vitro" 1 : 138-149, 2007

      6 Chien KR, "Stem cells : lost in translation" 428 : 607-608, 2004

      7 Matar AA, "Stem cell therapy for cardiac dysfunction" 3 : 440-, 2014

      8 Cristofalo VJ, "Relationship between donor age and the replicative lifespan of human cells in culture : a reevaluation reevaluation" 95 : 10614-10619, 1998

      9 Laugwitz KL, "Postnatal isl1 ? cardioblasts enter fully differentiated cardiomyocyte lineages" 433 : 647-653, 2005

      10 Teo AK, "Pluripotency factors regulate definitive endoderm specifi-cation through eomesodermin" 25 : 238-250, 2011

      11 Rubart M, "Physiological coupling of donor and host cardiomyocytes after cellular transplantation" 92 : 1217-1224, 2003

      12 Kuhn EN, "Origin of cardiac progenitor cells in the developing and postnatal heart" 225 : 321-325, 2010

      13 Nadal-Ginard B, "Myocyte death, growth, and regeneration in cardiac hypertrophy and failure" 92 : 139-150, 2003

      14 Boengler K, "Loss of ischemic preconditioning’s cardioprotection in aged mouse hearts is associated with reduced gap junctional and mitochondrial levels of connexin 43" 292 : 1764-1769, 2006

      15 Zhang X, "Isolation, culture and characterization of cardiac progenitor cells derived from human embryonic heart tubes" 190 : 194-208, 2009

      16 Miao Z, "Isolation of mesenchymal stem cells from human placenta : comparison with human bone marrow mesenchymal stem cells" 30 : 681-687, 2006

      17 Gonzales C, "Isolation of cardiovascular precursor cells from the human fetal heart" 18 : 198-207, 2012

      18 Srikanth GVN, "Isolation and characterization of cardiac MSCs from rat foetal hearts" 1 : 1-8, 2012

      19 Lunde K, "Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction" 355 : 1199-1209, 2006

      20 Montjovent MO, "In vitro characterization of immunerelated properties of human fetal bone cells for potential tissue engineering applications" 15 : 1523-1532, 2009

      21 Scha¨chinger V, "Improved clinical outcome after intracoronary administration of bone-marrowderived progenitor cells in acute myocardial infarction : final 1-year results of the REPAIR-At55MI trial" 27 : 2775-2783, 2006

      22 Go¨therstro¨m C, "Immunologic properties of human fetal mesenchymal stem cells" 190 : 239-245, 2004

      23 Kerr NM, "Immunolocalization of Gap Junction Protein Connexin43(GJA1)in the Human Retina and Optic Nerve" 51 : 4028-4034, 2010

      24 Campagnoli C, "Identification of mesenchymal stem/progenitor cells in human first-trimester fetal blood. liver, and bone marrow" 98 : 2396-2402, 2001

      25 Guillot PV, "Human first-trimester fetal MSC express pluripotency markers and grow faster and have longer telomeres than adult MSC" 25 : 646-654, 2007

      26 Jiang XX, "Human fetal heart-derived adherent cells with characteristics similar to mesenchymal progenitor cells" 14 : 1191-1194, 2006

      27 Rossini A, "Human cardiac and bone marrow stromal cells exhibit distinctive properties related to their origin" 89 : 650-660, 2011

      28 Sandstedt J, "Human C-kit? CD45-cardiac stem cells are heterogeneous and display both cardiac and endothelial commitment by singlecell qPCR analysis" 443 : 234-238, 2014

      29 Niwa H, "How is pluripotency determined and maintained" 134 : 635-646, 2007

      30 van Vliet P, "Foetal and adult cardiomyocyte progenitor cells have different developmental potential" 14 : 861-870, 2010

      31 Srikanth GVN, "Fetal cardiac mesenchymal stem cells express embryonal markers and exhibit differentiation into cells of all three germ layers" 5 : 26-33, 2013

      32 Loh KM, "Ex uno plures : molecular designs for embryonic pluripotency" 95 : 245-295, 2015

      33 Misfeldt AM, "Endocardial cells are a distinct endothelial lineage derived from Flk1? multipotent cardiovascular progenitors" 333 : 78-89, 2009

      34 허만일, "Effect of Conditioned Media Collected from Human Amniotic Fluid-Derived Stem Cells (hAFSCs) on Skin Regeneration and Photo-aging" 한국조직공학과 재생의학회 11 (11): 171-177, 2014

      35 Wang Z, "Distinct lineage specification roles for NANOG, OCT4, and SOX2 in human embryonic stem cells" 10 : 440-454, 2012

      36 Wu SM, "Developmental origin of a bipotential myocardial and smooth muscle cell precursor in the mammalian heart" 127 : 1137-1150, 2006

      37 Blasi A, "Dermal fibroblasts display similar phenotypic and differentiation capacity to fat-derived mesenchymal stem cells, but differ in anti-inflammatory and angiogenic potential" 8 : 5-, 2011

      38 Komuro I, "Csx : a murine homeobox-containing gene specifically expressed in the developing heart" 90 : 8145-8149, 1993

      39 Fang B, "Comparison of human post-embryonic, multipotent stem cells derived from various tissues" 31 : 929-938, 2009

      40 Kim M, "Comparison of Fetal Cartilage-Derived Progenitor Cells Isolated at Different Developmental Stages in a Rat Model" 58 : 167-179, 2016

      41 Fan CG, "Characterization and neural differentiation of fetal lung mesenchymal stem cells" 14 : 311-321, 2005

      42 Hidaka K, "Chamber-specific differentiation of Nkx2.5-positive cardiac precursor cells from murine embryonic stem cells" 17 : 740-742, 2003

      43 Buckingham M, "Building the mammalian heart from two sources of myocardial cells" 6 : 826-835, 2005

      44 Rose RA, "Bone marrow-derived mesenchymal stromal cells express cardiac-specific markers, retain the stromal phenotype, and do not become functional cardiomyocytes in vitro" 26 : 2884-2892, 2008

      45 Abdulrazzak H, "Biological characteristics of stem cells from foetal, cord blood and extraembryonic tissues" (Suppl. 6) : S689-S706, 2010

      46 Takahashi T, "Ascorbic acid enhances differentiation of embryonic stem cells into cardiac myocytes" 107 : 1912-1916, 2003

      47 Haniffa MA, "Adult human fibroblasts are potent immunoregulatory cells and functionally equivalent to mesenchymal stem cells" 179 : 1595-, 2007

      48 Chong JJ, "Adult cardiac–resident MSC-like stem cells with a proepicardial origin" 9 : 527-540, 2011

      49 Beltrami AP, "Adult cardiac stem cells are multipotent and support myocardial regeneration" 114 : 763-776, 2003

      더보기

      동일학술지(권/호) 다른 논문

      동일학술지 더보기

      더보기

      분석정보

      View

      상세정보조회

      0

      Usage

      원문다운로드

      0

      대출신청

      0

      복사신청

      0

      EDDS신청

      0

      동일 주제 내 활용도 TOP

      더보기

      주제

      연도별 연구동향

      연도별 활용동향

      연관논문

      연구자 네트워크맵

      공동연구자 (7)

      유사연구자 (20) 활용도상위20명

      인용정보 인용지수 설명보기

      학술지 이력

      학술지 이력
      연월일 이력구분 이력상세 등재구분
      학술지등록 한글명 : 조직공학과 재생의학
      외국어명 : Tissue Engineering and Regenerative Medicine
      2023 평가예정 해외DB학술지평가 신청대상 (해외등재 학술지 평가)
      2020-01-01 평가 등재학술지 유지 (해외등재 학술지 평가) KCI등재
      2013-10-01 평가 등재학술지 선정 (기타) KCI등재
      2012-01-01 평가 등재후보 1차 FAIL (기타) KCI등재후보
      2011-01-01 평가 등재후보 1차 PASS (등재후보1차) KCI등재후보
      2010-01-01 평가 등재후보 1차 FAIL (등재후보1차) KCI등재후보
      2008-01-01 평가 SCIE 등재 (신규평가) KCI등재후보
      더보기

      학술지 인용정보

      학술지 인용정보
      기준연도 WOS-KCI 통합IF(2년) KCIF(2년) KCIF(3년)
      2016 1.08 0.42 0.81
      KCIF(4년) KCIF(5년) 중심성지수(3년) 즉시성지수
      0.69 0.51 0.367 0.03
      더보기

      이 자료와 함께 이용한 RISS 자료

      나만을 위한 추천자료

      해외이동버튼